FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.

Cancer Sci · 2021 · PMC7780005 · PMID 33075166

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = .16not close (p > 0.1)

showed a trendno p-value reported

The OCP or OCA results demonstrated that enrichment of TP53 mutations showed a trend for higher frequency in FLT3 amplification mCRC patients compared with in non‐ FLT3 amplification patients, but the difference did not reach statistical significance ( P = .16).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.